Меню
КартаВръзкиТемиБългарияНощта (K-TRIO)Мария Склодовска-КюриЗа ученициЗа учителиМетодологияИзненадай ме
H2020Съфинансиране2016–2021

PRONKJEWAIL · Protecting patients with enhanced susceptibility to infections

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2016-09-01 → 2021-08-31
Финансиране от ЕС
1 674 240 €
Участници
27
Схема
MSCA-COFUND

Линиите свързват координатора с партньорите.

Накратко на български

Защитата на пациенти с повишена предразположеност към инфекции включва работа по ваксини, персонализирана диагностика и влиянието на лечението върху микробиома. Тези проучвания помагат за подобряване на болничната грижа и опазването на общественото здраве.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Protecting patients with enhanced susceptibility to infections

The Microbes in Health and Disease research programme at the University Medical Center Groningen (UMCG) proposed the Doctoral Training Programme PRONKJEWAIL (‘a real gem’) in the field of hospital care and infection. The specific training objective is ‘protecting patients with enhanced susceptibility to infections’. PRONKJEWAIL recruited 16 international PhD students, who were trained in research, transferable skills, and network and capacity building. They were guided by experienced supervisors from the departments of Medical Microbiology, Internal Medicine, Intensive Care, Clinical Pharmacy and Pharmacology, Paediatrics, Surgery, Cell Biology, and Pharmacoepidemiology and Pharmacoeconomics at the UMCG. 26 partner organisations, including 14 private sector partners, were committed to support ESR training via mentoring, courses and secondments. Research training built on four Pillars: 1) vaccines and primary prevention; 2) personalized detection and infection prevention; 3) iatrogenic influence on the microbiome and 4) personalized therapy/stewardship. Each Pillar integrated fundamental, translational and clinical/epidemiological training projects. The high exposure to fundamental, translational and clinical research in academia and industry increased the PhD students’ problem-solving capabilities. Further, PhD students learned to value mobility through internships at international partner organizations. The scientific results obtained by the PhD students have impact on hospital care and contribute to enhanced public health. By providing excellent training, PRONKJEWAIL developed new talent within the next generation of medical researchers thereby strengthening the European Research Area. Conclusions The Doctoral Training Programme PRONKJEWAIL has achieved the goals proposed. The focus on educating the next generation of European researchers has involved formal training, teamwork within the project through joint scientific projects between ESRs, and performing research in international teams generating 89 scientific articles written so far with organisations and companies across Europe and the world, offering ESRs the skills, knowledge, and networks in order to advance their careers and to continue contributing to the field of infectious diseases. The emphasis on patients with susceptibility to infections has become more relevant with the advent of the COVID-19 pandemic and Pronkjewail ESRs have seamlessly pivoted their work and training to reflect the new reality. The attention given during the project for cultural and work integration, quality of life, and work-life balance, whilst challenging ESRs to achieve excellence in their preferred academic field resulted in a successful project, with ESRs reporting satisfaction with their environment and all choosing to continue a career in research.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

The Microbes in Health and Disease research programme at the University Medical Center Groningen (UMCG) proposes the Doctoral Training Programme PRONKJEWAIL (‘a real gem’) in the field of hospital care and infection. The specific training objective is ‘protecting patients with enhanced susceptibility to infections’. PRONKJEWAIL will recruit 16 international ESRs, who will be trained in research, transferable skills, and network and capacity building. They will be guided by experienced supervisors from the departments of Medical Microbiology, Internal Medicine, Intensive Care, Clinical Pharmacy and Pharmacology, Rheumatology and Immunology, Surgery, Cell Biology, and Pharmacoepidemiology and Pharmacoeconomics at the UMCG. 26 partner organisations, including 14 private sector partners, are committed to support ESR training via mentoring, courses and secondments. Research training builds on four Pillars: 1) vaccines and primary prevention; 2) personalized detection and infection prevention; 3) iatrogenic influence on the microbiome and 4) personalized therapy/stewardship. Each Pillar integrates fundamental, translational and clinical/epidemiological training projects. The high exposure to fundamental, translational and clinical research in academia and industry will increase the ESRs future problem-solving capabilities.Further, ESRs will learn to value mobility through internships at international partner organizations. By providing an excellent scientific working environment PRONKJEWAIL will directly impact on hospital care and, ultimately, it will contribute to enhanced public health. By providing excellent training, PRONKJEWAIL will develop new talent within the next generation of medical researchers thereby strengthening the European Research Area.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз